(Q44217442)

30 November 2017

title

Factors predicting lack of adherence to highly active antiretroviral treatment (English)

1 reference

30 November 2017

author name string

Vicente Martín-Sánchez

1

1 reference

30 November 2017

Luis Ortega-Valín

2

1 reference

30 November 2017

María del Rosario Pérez-Simón

3

1 reference

30 November 2017

José Luis Mostaza-Fernández

4

1 reference

30 November 2017

Juan José Ortiz de Urbina-González

5

1 reference

30 November 2017

Miriam Rodríguez-María

6

1 reference

30 November 2017

José Antonio Carro-Fernández

7

1 reference

30 November 2017

María José Cuevas-González

8

1 reference

30 November 2017

Manuel Alcoba-Leza

9

1 reference

30 November 2017

Grupo de Trabajo sobre Adhesión a TARGA en la provincia de León

10

1 reference

30 November 2017

language of work or name

Spanish

0 references

publication date

1 December 2002

1 reference

Infectious Diseases and Clinical Microbiology

30 November 2017

published in

1 reference

30 November 2017

volume

20

1 reference

30 November 2017

issue

10

1 reference

30 November 2017

page(s)

491-497

1 reference

[Recommendations of the Spanish AIDS Study Group (GESIDA) and the National Aids Plan (PNS) for antiretroviral treatment in adult patients with human immunodeficiency virus infection in 2002].

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AAC

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Congruence of three self-report measures of medication adherence among HIV patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Provider assessment of adherence to HIV antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Long-term patient adherence to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Adherence and effectiveness of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Adherence in AIDS clinical trials: a framework for clinical research and clinical care

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

The Dynamic of Adherence to Highly Active Antiretroviral Therapy: Results From the French National APROCO Cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Sociodemographic and psychological variables influencing adherence to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Protease inhibitors in the homeless

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2802%2972851-6

7 January 2021

10.1016/S0213-005X(02)72851-6

Identifiers

DOI

1 reference

30 November 2017

1 reference